Patient P-01792

Synthetic patientNBL-101 · Day 112 · 25–34 · M · baseline S04Steering view · 3D Open companion preview

Therapy response

Declining

Tolerance

Favorable

GI state

Improving

Inflammatory state

Favorable

Nutritional resilience

Improving

Discontinuation risk

18%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S04

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

GI instability-8
Nutritional resilience+7
Treatment adherence+6
Inflammatory activity-2

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

23.3/100

improving · -12.2 vs previous 14 d

Toxicity

Blood

24.5/100

improving · -5.0 vs previous 14 d

Sleep quality

Wearable

68.9/100

improving · +10.8 vs previous 14 d

Energy level

Daily log

5.7/10

improving · +1.0 vs previous 14 d

Stress level

Daily log

4.9/10

improving · -0.9 vs previous 14 d

Steps

Wearable

4,243

improving · +764 vs previous 14 d

Adherence

Companion

92.7 %

stable · +1.6 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards restoration · 66 from the failing basin, 27 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.

Would not help

Keep spicy low
GI +4.2 next day on high-intake days · n 18

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Spicy / capsaicin
+4.2detractor · 95%
Simple carbohydrates
-2no signal · 52%
Alcohol
+1.6no signal · 34%
Histamine load
-0.8no signal · 20%
Dietary fat load
+0.7no signal · 17%
Insoluble fibre
-0.7no signal · 16%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Inflammatory signalling ↓25
- DNAIL6 -174 variant raises baseline inflammatory tone
Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted

DNA

Fictional pharmacogenomic panel

IL6 -174 G/C
Higher inflammatory tone
CYP2D6 Intermediate metabolizer
Expected exposure

Microbiome

Shannon diversity 4 · butyrate capacity 71/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiLow
Bacteroides fragilisNormal
Bifidobacterium longumLow
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 48 ms
Sleep: 8.0 h
Steps: 3,902
Resting HR: 60 bpm

Daily log: GI score 23, nutritional resilience 60, adherence 93.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
A 15-minute walk after lunch
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01571	48%	S13	SC-12	improved	57
P-01430	44%	S05	CR-01	improved	54
P-01342	41%	S11	DT-01	improved	48
P-01804	41%	S19	AD-05	improved	61
P-01346	39%	S12	DT-01	improved	52
P-01593	39%	S10	HY-01	improved	56
P-01724	39%	S10	DT-01	improved	63
P-01455	38%	S01	GI-04	improved	61
P-01861	38%	S12	HY-01	improved	47
P-01752	37%	S20	DT-01	improved	50
P-01374	35%	S08	HY-01	improved	49
P-01555	34%	S06	GI-04	improved	56